Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$67.5M
95M shares
52-week range
$0.40 – $5.33
6% from low
Exchange
NASDAQ
CS
P/S (TTM)
0.2
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
www.mdxhealth.comNo one on the platform currently holds MDXH.
No tracked institution reports a position in MDXH as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-11-14 | 1-for-10reverse |
No one on the platform has traded MDXH yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| Rev. Growth % | 19.8% | 42.3% | ||||
| Profit Margin % | -31.1% | -76.8% | -109.4% | |||
| Free Cash Flow Margin % | -10.7% | -56.0% | -79.8% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $111M | +2.0% | $-0.51 | $-0.52–$-0.49 | — | 3 |
| 2027 | $126M | +13.2% | $-0.28 | $-0.35–$-0.21 | — | 3 |
| 2028 | $140M | +11.6% | $-0.15 | $-0.29–$-0.03 | — | 3 |
| 2029 | $164M | +16.4% | $0.01 | $0.01–$0.01 | 68.0× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-13 | $-0.19 | $-0.18 | +6.9% |
| 2026-05-13 | $-0.13 | $-0.19 | -46.2% |
| 2025-11-12 | $-0.12 | $-0.16 | -33.3% |
| 2025-05-14 | $-0.13 | $-0.19 | -46.2% |
| 2024-11-06 | $-0.27 | $-0.40 | -48.1% |
| 2024-05-01 | $-0.30 | $-0.31 | -3.3% |
| 2023-11-08 | $-0.31 | $-0.40 | -29.0% |
| 2023-05-15 | $-0.40 |
| $-0.05 |
| +87.5% |
| $481M |
| — |
| QTRXQuanterix Corporation | $2.60 | +4.20% | $123M | — |
| SIShoulder Innovations, Inc. | $17.83 | -2.83% | $370M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$MDXH little birdie told me the company has confidence they will organically grow the SP past the $1.00 mark prior to the Dec 28th deadline, and a reverse split isnt in the cards (for now). Makes sense, since the companies recently bought in the financing wouldnt have participated if they thought that was a risk in the near term.
View on StockTwits ↗
$MDXH Just a cup that needed a handle. Half the handle has printed. The next couple of weeks, if volume shows up, could see us fill the gap to 1.80s.
View on StockTwits ↗
$MDXH Got my core position of 10,000 shares...long term hold...BULLISH
View on StockTwits ↗$MDXH 8000 shares now..my 3000 share order wouldn't fill...
View on StockTwits ↗
Watching potential squeezes for next week $AKTX $MDXH $ISPC
View on StockTwits ↗$MDXH looking really good...I will keep buying...5000 shares here
View on StockTwits ↗$MDXH were just sitting, waiting. Company forcasted growth for Q3 and Q4. Just a waiting game now :)
View on StockTwits ↗
$MDXH waiting on volume to send this back up and beyond!!
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.